Mallinckrodt Pharmaceuticals
Pharma & Biotech company headquartered in Hazelwood, MO. Cross-border supply chain, facility locations, and freight intelligence below.
Home | Introducing Keenova and Par Health # IntroducingKeenova and Par Health On July 31, 2025, Mallinckrodt and Endo joined together to better serve patients and customers with a bold plan for the future. Following the merger, the combined company then spun off its generics and sterile injectables business as an independent company—Par Health—and rebranded the specialty therapeutics company as Keenova Therapeutics in November 2025. Today, Keenova and Par Health operate as separate companies, ea
- Industry
- Pharma & Biotech
- Headquarters
- Hazelwood, MO
- Employees
- 3000
- Revenue
- $2.3B
- US facilities
- Hazelwood, MO · St. Louis, MO
Start a free trial to see Mallinckrodt Pharmaceuticals’s full freight profile — facility network, cross-border lanes, and shipper intelligence.